Acta Scientific Medical Sciences (ASMS)(ISSN: 2582-0931)

Research Article Volume 7 Issue 1

An Assessment Report on the Symptoms Following Covid-19 Vaccinated Population

Tiyas Saha1, Monosiz Rahaman1, Aritra Saha1, Sejuti Ray Chowdhury1, Debasmita Dutta Roy1, Arijit Das1, Aditya Prasanna Mukherjee1, Suraj Kumar Shah3, Bitasta Mandal1, Nandan Sarkar1 and Sourav De2*

1Department of Pharmaceutical Technology, School of Medical Sciences, Adamas University, Barasat, Kolkata, West Bengal, India
2Department of Chemical Engineering, National Chung Cheng University, Chia-Yi, Taiwan, ROC
3Department of Biotechnology, Bhupat and Jyoti Mehta School of Biosciences, IIT Madras, Chennai, India

*Corresponding Author: Sourav De, Department of Chemical Engineering, National Chung Cheng University, Chia-Yi, Taiwan, ROC.

Received: November 21, 2022; Published: December 29, 2022

Abstract

Objectives: The off-late emerged corona virus 2019 (COVID-19), which was brought by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) had a significant negative impact in human health. Multiple vaccines were developed and delivered in just one year after the epidemic began. The effectiveness of several new vaccinations significantly exceeded expectations, and there is a good chance that the COVID-19 will be nullified soon. However, several challenges still persist. The idea of advanced countries' vaccination programs is far developed means that the world's population will soon acquire protective immunity to this dreadful disease. Additionally, vaccine hesitancy is a major problem, particularly in young people who often deal with COVID-19 well and exhibit few to no symptoms. The remarkable side-effects related to the COVID-19 vaccine are well documented. In the present study, we focused on the determination of substantial side-effects observed after COVID-19 vaccination in local population of Kolkata region, West Bengal, India.

Methods: We have prepared the survey questionnaire in order to determine the side effects experienced by the people, who were vaccinated (1st or 2nd or both) against COVID-19. Due to the pandemic situation, it was difficult to conduct the survey by physical interaction with the people living in the Kolkata region of West Bengal. So, the survey was conducted via virtual mode through some social networking sites.

Key Findings: The total number of candidates for this study was near to hundreds, from the Kolkata and its nearest areas. This survey will help us to find out the current scenario related to Covid-19 vaccination, and the survey is done in Kolkata region.

Conclusions: The survey will allow the readers to understand the efficacy of COVID-19 vaccines. The respondents experienced mild to severe side effects. However, the efficacies of COVID-19 vaccines were found to be good.

Keywords: Covid-19; Coronaviridae; Covishield; Covaxin; MERS; Remdesivir; SARS

References

  1. Technical interim guidance for novel coronavirus, WHO.
  2. WHO travel advice for international travel and trade in relation to the outbreak of pneumonia caused by a new coronavirus in China (2020).
  3. Almeida JD and Tyrrell DA. “The morphology of three previously uncharacterized human respiratory viruses that grow in organ culture”. Journal of General Virology 2 (1967): 175-178.
  4. Kapikian AZ., et al. “Isolation from man of “avian infectious bronchitis viruslike” viruses (coronaviruses) similar to 229E virus, with some epidemiological observations”. Journal of Infectious Disease3 (1969): 282-90.
  5. Peiris JS., et al. “Severe acute respiratory syndrome”. Nature Medicine12 (2004): S88-97.
  6. van der Hoek L., et al. “Identification of a new human coronavirus”. Nature Medicine4 (2004): 368-373.
  7. Wevers BA and van der Hoek L. “Recently discovered human coronaviruses”. Clinics in Laboratory Medicine 4 (2009): 715-724.
  8. Zhu Y., et al. “A novel human coronavirus OC43 genotype detected in mainland China”. Emerging Microbes and Infections1 (2018): 173.
  9. Wang D., et al. “Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China”. JAMA11 (2020): 1061.
  10. Chen N., et al. “Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study”. Lancet 10223 (2020): 507-513.
  11. Bai Y., et al. “Presumed asymptomatic carrier transmission of COVID-19”. JAMA (2020).
  12. van Doremalen N., et al. “Stability of Middle East respiratory syndrome coronavirus (MERS-CoV) under different environmental conditions”. Eurosurveillance38 (2013): 20590.
  13. https://www.acponline.org/
  14. Paules CI., et al. “Coronavirus Infections-More Than Just the Common Cold”. JAMA (2020).
  15. Reliefweb: Johns Hopki University. Coronavirus COVID-19 Global Cases by Johns Hopkins CSSE.
  16. Dong E., et al. “An interactive web-based dashboard to track COVID- 19 in real time”. The Lancet Infectious Disease (2020).
  17. https://ourworldindata.org/covid-vaccinations/
  18. Ranga V., et al. “National health-GIS portal-A conceptual framework for effective epidemic management and control in India”. Preprints (2020): 2020060325.
  19. https://www.cdc.gov/coronavirus/2019-ncov/vaccines/expect/after.html
  20. https://www.mohfw.gov.in/covid_vaccination/vaccination/common-side-effects- aefi.html
  21. https://www.cdc.gov/coronavirus/2019-ncov/hcp/therapeutic-options.html
  22. https://www.health.harvard.edu/diseases-and-conditions/treatments-for-covid-19

Citation

Citation: Sourav De., et al. “An Assessment Report on the Symptoms Following Covid-19 Vaccinated Population”.Acta Scientific Medical Sciences 7.1 (2023): 92-103.

Copyright

Copyright: © 2022 Sourav De., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.




Metrics

Acceptance rate30%
Acceptance to publication20-30 days
Impact Factor1.403

Indexed In





News and Events


  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is February 15, 2023.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of “Best Article of the Issue”.
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.
  • Contact US